retatrutide better than mounjaro vs Mounjaro: triple agonist versus dual agonist compared Retatrutide vs. Tirzepatide: What's The

That has a clinical knock-on effect

Weight loss can disrupt the hair growth cycle

Additionally, while the human islet donors did not have T2DM, these islet donors had BMIs consistent with an overweight condition

demonstrated superiority of GLP-1 RAs over metformin in improving erectile function ( p = 0.02), with greater benefits in men with BMI 30 kg/m 2 ( p = 0.02) [171]

Scope: Comprehensive review of ANGPTL3 inhibition as a therapeutic strategy to reduce triglyceride-rich lipoproteins and residual cardiovascular risk Therapeutic approaches discussed: Monoclonal antibodies (e.g., evinacumab) RNA-based therapies (ASOs and siRNA: vupanorsen, zodasiran, solbinsiran) Emerging gene-editing strategies (CRISPR/base editing) Key message: Targeting ANGPTL3 provides robust reductions in triglycerides, apoB-containing lipoproteins, and non-HDL cholesterol, independently of the LDL receptor Clinical relevance: Positions ANGPTL3 inhibition as a next-generation approach for managing mixed dyslipidemia and lipid-related residual risk beyond LDL-C Laura Schreier Natalia Nardelli European Atherosclerosis Society To view or add a comment, sign in Tipping the Scale in MASH: The TZD vs